Coagulation biomarkers and prediction of venous thromboembolism and survival in small cell lung cancer: A sub-study of RASTEN - A randomized trial with low molecular weight heparin.

Coagulation biomarkers and prediction of venous thromboembolism and survival in small cell lung cancer: A sub-study of RASTEN - A randomized trial with low molecular weight heparin.

Coagulation activation and venous thromboembolism (VTE) are hallmarks of cancer; however, there is an unmet need of improved biomarkers for individualized anticoagulant treatment. The present sub-study of the RASTEN trial was designed to explore the role of coagulation biomarkers in predicting VTE r...

Full description

Bibliographic Details
Main Authors: E Gezelius, A Flou Kristensen, P O Bendahl, Y Hisada, S Risom Kristensen, L Ek, B Bergman, M Wallberg, U Falkmer, N Mackman, S Pedersen, M Belting
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC6226210?pdf=render

Internet

http://europepmc.org/articles/PMC6226210?pdf=render

Similar Items